Aitia
Pre-clinicalAitia harnesses Causal AI, Multi-Omics data and Gemini Digital Twins to discover the next generation of breakthrough drugs.
Founded
2019
Focus
AI / Machine LearningDrug Discovery
About
Aitia harnesses Causal AI, Multi-Omics data and Gemini Digital Twins to discover the next generation of breakthrough drugs.
Funding History
4Total raised: $78M
Series B$20MSection 32Jan 15, 2023
Series A$40MKhosla VenturesJan 15, 2022
Series A$10MSection 32Jun 15, 2021
Seed$8MKhosla VenturesJun 15, 2020
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile